The Effects of Jing Si Herbal Tea on Physical and Psychological Symptoms in Peripheral Blood Hematopoietic Stem Cell Donors

September 15, 2025 updated by: Buddhist Tzu Chi General Hospital
This study aim to explore the impact of Jing Si Herbal Tea on pain and emotional stress in peripheral blood stem cell donors.

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hualien City, Taiwan, 970
        • Hualiien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • health Men or women aged 20 to 55 years old
  • willing to take Jing Si Herbal Drink

Exclusion Criteria:

  • no willing to take Jing Si Herbal Drink;
  • Previously already take Jing Si Herbal Drink daily

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: NORMAL
daily diet
Jing Si Herbal Drink
No Intervention: Take Jing Si Herbal Drink
Take Jing Si Herbal Drink daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in pain assessed by questionnaires
Time Frame: 5 day

For each of the pain sites includes: headache、bone、joint & muscle, indicate the severity of present using the following scale (baseline vs. follow-up).

grade 0: fully active, able to carry on all pre-disease performance without restriction

grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work

grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours

grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours

grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair

grade 5: dead

5 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in anxiety assessed by questionnaires
Time Frame: 21 days

Difference in donor Health State Trait Anxiety Index (STAI) scores (baseline vs. follow-up).

The STAI questionnaire consists of 20 items for assessing "state anxiety" and 20 items for assessing "trait anxiety," with a raw score of 20 to 60 points for each scale.

The state anxiety scale evaluates the current state of anxiety associated with a special situation, measuring subjective feelings of apprehension, tension, nervousness, worry, and activation of the autonomic nervous system, whereas the trait anxiety scale evaluates proneness to anxiety .

The level of anxiety was determined according to the percentile rank obtained using the raw score of each questionnaire and was classified as low anxiety (1st-23th percentile), moderate anxiety (25th75th percentile) and high anxiety (77th-99th percentile).

21 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 18, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

November 5, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Actual)

November 21, 2023

Study Record Updates

Last Update Posted (Estimated)

September 19, 2025

Last Update Submitted That Met QC Criteria

September 15, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB111-125-A
  • IMAR-111-01-17 (Other Grant/Funding Number: BuddhistTCGH)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotional Stress

Clinical Trials on Jing Si Herbal Drink

Subscribe